Ensovibep, a novel trispecific DARPin candidate that protects against SARS-CoV-2 variants
S. Rothenberger, D. L. Hurdiss, M. Walser…·Vassell
This paper describes ensovibep, a trispecific DARPin that inhibits SARS-CoV-2 variants by targeting the spike protein, showing potent antiviral activity and protection in animal models.